IGF1 and cystic fibrosis-related diabetes: In vitro the (2560)/total FOXO1 ratio was normalized by IGF-I treatment, and the datum was confirmed in the muscle and less but also, in white adipose tissue of affected mice, supporting the hypothesis that it could be a possible candidate for the treatment and/or prevention of CFRD.